May Health will have you looking at ovarian ablation and its success rates in a whole new way.
If you’ve heard of Laparoscopic Ovarian Drilling (LOD), you know there’s clinical evidence of its ability to achieve ovulation at a rate of 30-90% and successful pregnancy at a rate of 13-88% (Source: Seow 2020).
You likely also know that LOD is surgical, requiring patients to be put under general anesthesia in an operating room and to anticipate a recovery time of about one to two weeks. The invasiveness and cumbersome nature of the procedure has made LOD an unlikely avenue for PCOS patients, despite the years of clinical evidence demonstrating the effectiveness of LOD in resetting ovarian function, until now.
May Health has set out to bring patients and physicians the promise of this clinical evidence with a revolutionized device and modernized, one-time treatment that can be done conveniently at the physician’s office.
With a modernized approach comes a modern name: Ovarian Rebalancing™REBALANCE Study
What Makes it Modern?
Leverages an established fertility procedure:
- Accessing the ovary in the same minimally invasive way as ultrasound-guided transvaginal egg retrieval (routinely used for IVF).
Key safety features include:
- Transvaginal access, no transabdominal incisions
- Echogenic needle for visualization
- Catheter anchors into the ovary
- Custom radiofrequency generator with temperature control
How it Works
The needle located on the May Health device includes a catheter that delivers radiofrequency (RF) energy to ovarian tissue.
2.The basis for applying RF energy to ablate ovarian tissue is to decrease the level of androgen production.
3.By lowering androgen levels, ovulation can often be restored.
Get the latest on May Health’s clinical study and information about PCOS.We’ll Keep You Updated